FindTrial
Sign In

Assessing the Performance of a New X-ray Irradiation System for Blood Products

Validation of a novel self contained X-ray blood irradiator system for Irradiation of Blood and Blood Components - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108858
Enrollment
12
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Ministry of electronics and information technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Donors who are fulfilling Drugs and Cosmetic Act, 1940 Donor eligibility criteria and Departmental SOP.

Exclusion criteria

Exclusion criteria: Donors not fulfilling Drugs and Cosmetic Act, 1940 Donors eligibility criteria, Departmental SOP and donors who did not consent to participate.

Design outcomes

Primary

MeasureTime frame
To evaluate efficiency of novel self-contained X-ray irradiator for irradiating cellular blood components intended for transfusion.Timepoint: 6 months—

Secondary

MeasureTime frame
1.To compare the efficacy of X-ray irradiator with gamma irradiator. 2. To assess the effect of irradiation on the biochemical parameters of the blood components. 3. To evaluate the effect of irradiation on platelet function tests. 4. To confirm the absence of T-lymphocyte proliferation post irradiation process.Timepoint: 6 months—

Countries

India

Contacts

Public ContactAswathi Suresh

Tata Memorial Hospital

dr_priti99@yahoo.com9987815691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026